Tag: Aurobindo Pharma

Stock that will see action today: November 20

Cipla has received a Warning Letter dated November, 17 (Sunday) from United States Food and Drug Administration (USFDA) for the

Sensex, Nifty updates on 23 October 2023: Benchmark equity indices Sensex and Nifty plunged more than 1 per cent on

Drugmaker Aurobindo Pharma on Monday announced that its wholly-owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from

Leading drug makers Sun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing

Illustration: Ajay Mohanty Aurobindo Pharma on Saturday said its consolidated net profit increased 10 per cent to Rs 571